NCT00115167View on ClinicalTrials.gov

A Study of Darbepoetin Alfa in Anemic Subjects Not Receiving Chemotherapy Who Have Completed the 20010103 Study

PHASE3CompletedINTERVENTIONAL
Enrollment

371

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

January 31, 2007

Study Completion Date

March 31, 2007

Conditions
AnemiaCancer
Interventions
DRUG

Placebo

Q4W

DRUG

Darbepoetin alfa

Q4W

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY

NCT00115167 - A Study of Darbepoetin Alfa in Anemic Subjects Not Receiving Chemotherapy Who Have Completed the 20010103 Study | Biotech Hunter | Biotech Hunter